Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer

被引：29

作者：

Kuppen, Malou C. P. ^{[1
]}

Westgeest, Hans M. ^{[2
]}

van der Doelen, Maarten J. ^{[3
]}

van den Eertwegh, Alphonsus J. M. ^{[4
]}

Coenen, Jules L. L. M. ^{[5
]}

Aben, Katja K. H. ^{[6
,7
]}

van den Bergh, Alphons C. M. ^{[8
]}

Bergman, Andries M. ^{[9
]}

van den Bosch, Joan ^{[10
]}

Celik, Filiz ^{[11
]}

Hendriks, Mathijs P. ^{[12
]}

Lavalaye, Jules ^{[13
]}

van der Meer, Saskia ^{[14
]}

Polee, Marco B. ^{[15
]}

Somford, Diederik M. ^{[16
]}

van Oort, Inge M. ^{[17
]}

Uyl-de Groot, Carin A. ^{[1
]}

Gerritsen, Winald R. ^{[3
]}

机构：

[1] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Inst Med Technol Assessment, Rotterdam, Netherlands

[2] Amphia Hosp, Dept Internal Med, Breda, Netherlands

[3] Radboud Univ Nijmegen, Dept Med Oncol, Med Ctr, Nijmegen, Netherlands

[4] Vrije Univ, Canc Ctr Amsterdam, Dept Med Oncol, Amsterdam UMC, Amsterdam, Netherlands

[5] Isala, Dept Oncol, Zwolle, Netherlands

[6] Radboud Univ Nijmegen, Dept Hlth Evidence, Med Ctr, Nijmegen, Netherlands

[7] Netherlands Comprehens Canc Org, Utrecht, Netherlands

[8] Univ Med Ctr Groningen, Dept Radiat Oncol, Groningen, Netherlands

[9] Netherlands Canc Inst, Div Internal Med MOD & Oncogen, Antoni van Leeuwenhoek Hosp, Amsterdam, Netherlands

[10] Albert Schweitzer Ziekenhuis, Dept Internal Med, Dordrecht, Netherlands

[11] Deventer Hosp, Dept Nucl Med, Deventer, Netherlands

[12] Northwest Clin, Dept Internal Med, Alkmaar, Netherlands

[13] St Antonius Hosp, Dept Nucl Med, Nieuwegein, Netherlands

[14] Jeroen Bosch Hosp, Dept Urol, sHertogenbosch, Netherlands

[15] Med Ctr Leeuwarden, Dept Internal Med, Leeuwarden, Netherlands

[16] Canisius Wilhelmina Hosp, Dept Urol, Nijmegen, Netherlands

[17] Radboud Univ Nijmegen, Dept Urol, Med Ctr, Nijmegen, Netherlands

来源：

FUTURE ONCOLOGY | 2020年 / 16卷 / 19期

关键词：

metastatic castration-resistant prostate cancer; radium-223; real-world outcomes; sequencing; skeletal-related events; survival; BONE METASTASES; DOUBLE-BLIND; THERAPY; PHASE-3; TRIAL; RECOMMENDATIONS; EXPERIENCE; EFFICACY; EVENTS; CYCLES;

D O I：

10.2217/fon-2020-0039

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Aim: Timing of radium-223 (Ra-223) in metastatic castration-resistant prostate cancer (mCRPC) remains challenging due to alternative options and short window of opportunity. Methods: Ra-223 treated patients in the CAPRI-registry were included. Outcomes were evaluated based on treatment line of Ra-223. Results: Out of 285 patients, 49% received Ra-223 in line >= 3. 51% completed six Ra-223 injections and 34% had a symptomatic skeletal event after first Ra-223 without differences between subgroups. After correction of known prognostic factors Ra-223 in line >= 3 (HR: 3.267; 95% CI: 1.689-6.317; p < 0.01) remained associated with worse OS. Conclusion: In the Netherlands, Ra-223 was mainly started as second or third mCRPC-treatment in 2014-2018. Later timing of Ra-223 did affect OS, but not treatment completion and occurrence of symptomatic skeletal events.

引用

页码：1371 / 1384

页数：14

共 50 条

[41] Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer
Peters, Michel L.
de Meijer, Claudine
Wyndaele, Dirk
Noordzij, Walter
Leliveld-Kors, Annemarie M.
van den Bosch, Joan
van den Berg, Pieter H.
Baka, Agni
Gaultney, Jennifer G.
[J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2018, 16 (01) : 133 - 143
[42] Evaluating radium-223 response in metastatic castration-resistant prostate cancer with imaging
Iizuka, Junpei
[J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 16 - 23
[43] Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer
Du, Yong
Carrio, Ignasi
De Vincentis, Giuseppe
Fanti, Stefano
Ilhan, Harun
Mommsen, Caroline
Nitzsche, Egbert
Sundram, Francis
Vogel, Wouter
Oyen, Wim
Lewington, Val
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (10) : 1671 - 1678
[44] Effectiveness and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and bone metastases in real-world practice: A multi-institutional study
Matsumoto, Takashi
Hori, Yoshifumi
Shiota, Masaki
Blas, Leandro
Nakamura, Motonobu
Seki, Narihito
Kuroiwa, Kentaro
Yokomizo, Akira
Morokuma, Futoshi
Kiyoshima, Keijiro
Eto, Masatoshi
[J]. INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (02) : 139 - 146
[45] Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer
Armstrong, Andrew J.
Gupta, Santosh
Healy, Patrick
Kemeny, Gabor
Leith, Beth
Zalutsky, Michael R.
Spritzer, Charles
Davies, Catrin
Rothwell, Colin
Ware, Kathryn
Somarelli, Jason A.
Wood, Kris
Ribar, Thomas
Giannakakou, Paraskevi
Zhang, Jiaren
Gerber, Drew
Anand, Monika
Foo, Wen-Chi
Halabi, Susan
Gregory, Simon G.
George, Daniel J.
[J]. PLOS ONE, 2019, 14 (05):
[46] Radium-223 in Metastatic Castration Resistant Prostate Cancer (mCRPC): a Single Cancer Centre Experience
Tsoukalas, N.
Morgui, M. Saigi
Mills, C.
Lewington, V.
Chowdhury, S.
Rudman, S.
[J]. CLINICAL ONCOLOGY, 2016, 28 (05) : E15 - E15
[47] Real-world utilization of radium-223 (Ra-223) for the treatment of metastatic castration-resistant prostate cancer (mCRPC): A US tertiary oncology center analysis
McKay, Rana R.
Silver, Rebecca
Bhak, Rachel
Korves, Caroline
Cheng, Mu
Appukkuttan, Sreevalsa
Simmons, Stacey J.
Duh, Mei Sheng
Taplin, Mary-Ellen
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
[48] Residents' Guide to Radium-223 Dichloride Treatment For Metastatic Prostate Cancer
Ersahin, Devrim
Chen, Ming-Kai
[J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57
[49] Real-world safety and effectiveness of radium-223 in patients with metastatic castration-resistant prostate cancer: Interim analyses of the prospective, observational RAPIT study
Huang, Chao-Yuan
Huang, Chi-Ping
Huang, Yu-Yi
Huang, Steven Kuan-Hua
Lu, Kevin
Huang, William Ji-Sien
Meng, En
Huang, Shu-Pin
Lee, Ming-Yang
Chen, Frank
Pang, See-Tong
[J]. INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (07) : 1268 - 1277
[50] Clinical response to radium-223 dichloride in men with metastatic castrate-resistant prostate cancer
Zhang, Isabella
Gilbo, Philip
Kohn, Nina
Cox, Brett
[J]. PRACTICAL RADIATION ONCOLOGY, 2018, 8 (06) : 452 - 457

← 1 2 3 4 5 →